The Inhibitory Activity of Polygonum Multiflorum Thunberg and its Effect on Postprandial Hyperglycemia in Streptozotocin-induced Diabetic Rats |
Kang Min-Jung
(Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Kim Jung-In (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Joo Hee-Jeong (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Seo Tae-Jin (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Kim Hyun-Ah (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Han Jung-Hee (Department of Nutrition, Pusan Paik Hospital) |
1 | King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-31, 1998 |
2 | The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in the diabetes control in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993 DOI ScienceOn |
3 | Haller H. The clinical importance of postprandial glucose. Diabetes Res Clin Pract 40:S43-49, 1998 DOI ScienceOn |
4 | Saito N, Sakai H, Sekihara H, Yajima Y. Effect of an -glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes subjects. J lnt Med Res 26:219-232, 1998 |
5 | Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y, Oki T, Osajima Y. In vitro survey of -glucosidase inhibitory food components. Biosci Biotechnol Biochem 60:2019-2022, 1996 DOI ScienceOn |
6 | Fujita H, Yamagami T, Ohshima K. Fermented soybean-derived touchi extract with anti-glycaemic effect via -glucosidase inhibitory action in rats and humans. J Nutr 131:1211-1213, 2001 |
7 | Mooradian AD, Thurman JE. Drug therapy of postprandial hyperglycemia. Drugs 57:19-29, 1999 |
8 | Baron AD. Postprandial hyperglycaemia and -glucosidase inhibitors. Diabetes Res Clin Pract 40:S51-55, 1998 DOI ScienceOn |
9 | Korea National Statistical Office: The cause of death Statistics 2001. Annual Report of on the Cause of Death Statistics. Korea National Statistical Office, Seoul, Korea, 2002 |
10 | UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317:703-713, 1998 DOI ScienceOn |
11 | Youn JY, Park HY, Cho KH. Anti-hyperglycemic activity of Commelina communis L.: inhibition of -glucosidase. 66S:S149-155, 2004 |
12 | Jenkins DJ, Wolever TM, Jenkins AL. Starchy foods and glycemic index. Diabetes Care 11:149-159, 1988 DOI ScienceOn |
13 | Sels JP, Huijberts MS, Wolffenbuttel BH. Miglitol, a new alpha-glucosidase inhibitor. Espert Opin Pharmacother 1:149-156, 1999 DOI ScienceOn |
14 | Centers for Disease Control and Prevention. Diabetes Surveillance Report, Atlanta, GA: US Department of Health and Human Services. 1999 |
15 | Shim YJ, Doo HK, Ahn SY, Kim YS, Seong JK, Park IS, Min BH. Inhibitory effect of aqueous extract from the gall of Rhus Chinensis on alpha-glucosidase activity and postprandial blood glucose. J Ethnopharmacol 85:283-287, 2003 DOI ScienceOn |
16 | Hanefeld M. The Role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complications 12:228-237, 1998 DOI PUBMED ScienceOn |
17 | Li Y, Wen S, Kota BP, Peng G, Li GQ, Yamahara J, Roufogalis BD. Punica granatum flower extract, a potent -glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol 99:239-244, 2005 DOI ScienceOn |
18 | Mooradian AD, Jerome E. Drug therapy of postprandial hyperglycemia. Drugs 57:19-29, 1999 |
19 | Lee SS, Lee SJ, Kim KH. Effect of Jiao Teng-Yuan on oxidation stress caused by D-galactose in Sprague-Dawley rats. J Korean Oriental Med 25:194-206, 2004 |
20 | Watanabe J, Kawabata J, Kurihara H, Niki R. Isolation and identification of -glucosidase inhibitors from Tochu-cha (Encommia ulmoides). Biosci Biotechnol Biochem 61:177-178, 1997 DOI ScienceOn |
21 | Nishioka T, Kawabata J, Aoyama Y. Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis. J Nat Prod 61:1413-1415, 1998 DOI ScienceOn |
22 | WHO. Medicinal Plants in China 2nd ed. pp.229, 1997 |
23 | Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826, 1997 DOI ScienceOn |
24 | Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. Acarbose controls postprandial hyper-proinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Prac 36:143-151, 1997 DOI ScienceOn |
25 | Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res Clin Pract 46:23-27, 1999 DOI ScienceOn |
26 | Bastyr EJ, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE. (IOEZ Study Group): Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care 23:1236-1241, 2000 DOI ScienceOn |
27 | Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-827, 2001 DOI PUBMED ScienceOn |
28 | Stand E, Baumgartl HJ, Fuchtenbusch M, Stemplinger J. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1:215-220, 1999 DOI ScienceOn |
29 | Mooradian AD, Thurman JE. Drug therapy of post-prandial hyperglycaemia. Drugs 57:19-29, 1999 |